Adaptive pathway development for Fabry disease: a clinical approach.

Schuller, Yvonne; Arends, Maarten; Körver, Simon; Langeveld, Mirjam; Hollak, Carla E M

Schuller, Yvonne; Arends, Maarten; Körver, Simon; Langeveld, Mirjam; Hollak, Carla E M.

Afiliação

Schuller Y; Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Arends M; Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Körver S; Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Langeveld M; Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Hollak CEM; Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: c.e.hollak@amc.uva.nl.

Drug Discov Today ; 23(6): 1251-1257, 2018 06.

Article em En | MEDLINE | ID: mdl-29455022

Assuntos

Terapia de Reposição de Enzimas; Doença de Fabry/tratamento farmacológico; Isoenzimas/uso terapêutico; alfa-Galactosidase/uso terapêutico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Fabry / Alfa-Galactosidase / Terapia de Reposição de Enzimas / Isoenzimas Tipo de estudo: Health_technology_assessment Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google